Search

everythinglearnresearchcommunity

for

Search:↓

Apoptosis contributes to hair loss in androgenetic alopecia.

Minoxidil promotes hair regrowth in early baldness stages and prevents baldness in non-bald scalps.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Minoxidil promotes hair growth but exact mechanism is unknown.

The document says that there are treatments for hair and nail diseases.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

The place where hair is transplanted can change its growth rate and length but not its thickness.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Laser device increases hair density, safe for treating hair loss in men and women.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Scientists created early-stage hairs from mouse cells that grew into normal, pigmented hair when implanted into other mice.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

The document suggests "anisotrichosis" as a new term for hair thickness variation in common baldness.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Androgens can both increase body hair and cause scalp hair loss.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Zinc pyrithione dissolves quickly on the skin and in hair follicles, especially in smaller particles.